FULTP
FULTON FINANCIAL CORP
$18.42
+0.77%
$3.5B
No data for this timeframe.
Vol
Market Cap$3.5B
Cap SizeMid Cap
SEC Reports4
Recent Activity
May 28, 2026
SEC
Fulton Financial Corporation filed an 8-K reporting the retirement of director George K. Martin at the 2026 Annual Meeti
8-K — Impact 2/10
Apr 27, 2026
SEC
Fulton Financial Corporation disclosed preliminary first-quarter 2026 financial results and strategic updates via an inv
8-K — Impact 6/10
Apr 22, 2026
SEC
Fulton Financial reported Q1 2026 earnings with diluted EPS of $0.51, missing consensus by 3.8% due to a $14.4M provisio
8-K — Impact 4/10
Analyst Ratings
3Strong Buy
5Buy
4Hold
0Sell
0Strong Sell
Latest Reports
NEUTRAL
8-K
2/10
Fulton Financial Corporation filed an 8-K reporting the retirement of director George K. Martin at the 2026 Annual Meeti
May 28, 2026
BULLISH
8-K
6/10
Fulton Financial Corporation disclosed preliminary first-quarter 2026 financial results and strategic updates via an inv
Apr 27, 2026
No institutional holding data available yet. Data is sourced from 13F filings which are filed quarterly.
No insider trading data available yet. Insider transactions are collected from SEC Form 4 filings.
4 SEC filing reports analyzed. Sentiment: 1 bullish, 0 bearish, 0 mixed, 3 neutral. Avg impact: 3.8/10.
NEUTRAL
8-K
2/10
Fulton Financial Corporation filed an 8-K reporting the retirement of director George K. Martin at t
May 28, 2026
BULLISH
8-K
6/10
Fulton Financial Corporation disclosed preliminary first-quarter 2026 financial results and strategi
Apr 27, 2026
NEUTRAL
8-K
4/10
Fulton Financial reported Q1 2026 earnings with diluted EPS of $0.51, missing consensus by 3.8% due
Apr 22, 2026
NEUTRAL
DEFA14A
3/10
Fulton Financial Corporation filed a definitive proxy statement for its 2026 annual meeting, where s
Apr 1, 2026
No press releases analyzed yet. Press releases are collected from GlobeNewsWire and analyzed by the LLM pipeline.
Historical analyst distribution: 67% buy across 12 analysts — 3 strong buy, 5 buy, 4 hold, 0 sell, 0 strong sell. No current recommendation available.
Earnings Estimates & Revisions
| Period | EPS Avg | EPS Low | EPS High | EPS Growth | 30d Rev. | Up/Down | Rev. Avg | Rev. Growth | Analysts |
|---|---|---|---|---|---|---|---|---|---|
| Current Q 2026-06-30 |
$0.00 | $0.00 | $0.00 | — | — | — | $0.4B | 10.9% | — |
| Next Q 2026-09-30 |
$0.00 | $0.00 | $0.00 | — | — | — | $0.4B | 10.4% | — |
| Current FY 2026-12-31 |
$0.00 | $0.00 | $0.00 | — | — | — | $1.4B | 9.5% | — |
| Next FY 2027-12-31 |
$0.00 | $0.00 | $0.00 | — | — | — | $1.5B | 5.8% | — |
Monthly Consensus History
| Period | Strong Buy | Buy | Hold | Sell | Strong Sell | Buy % | Distribution |
|---|---|---|---|---|---|---|---|
| Jun 1, 2026 | 3 | 5 | 4 | 0 | 0 | 67% | |
| May 1, 2026 | 3 | 5 | 4 | 0 | 0 | 67% | |
| Apr 1, 2026 | 3 | 5 | 4 | 0 | 0 | 67% | |
| Mar 1, 2026 | 3 | 4 | 4 | 0 | 0 | 64% | |
| Feb 1, 2026 | 4 | 4 | 3 | 0 | 0 | 73% | |
| Jan 1, 2026 | 4 | 4 | 3 | 0 | 0 | 73% |
Strong BuyBuyHoldSellStrong Sell
No congressional trading data available for this ticker. Data is sourced from Senate and House financial disclosure filings.
No Reddit sentiment data available yet. Sentiment is analyzed from Reddit investment communities on a rolling basis.
No events recorded for this ticker. Events include FDA actions, clinical trials, enforcement actions, and market-moving developments.